These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

321 related items for PubMed ID: 21763291

  • 1. Research update: Alpha7 nicotinic acetylcholine receptor mechanisms in Alzheimer's disease.
    Parri HR, Hernandez CM, Dineley KT.
    Biochem Pharmacol; 2011 Oct 15; 82(8):931-42. PubMed ID: 21763291
    [Abstract] [Full Text] [Related]

  • 2. Functional interactions of fibrillar and oligomeric amyloid-β with alpha7 nicotinic receptors in Alzheimer's disease.
    Lilja AM, Porras O, Storelli E, Nordberg A, Marutle A.
    J Alzheimers Dis; 2011 Oct 15; 23(2):335-47. PubMed ID: 21116052
    [Abstract] [Full Text] [Related]

  • 3. Modulation of α7 nicotinic acetylcholine receptor and fibrillar amyloid-β interactions in Alzheimer's disease brain.
    Ni R, Marutle A, Nordberg A.
    J Alzheimers Dis; 2013 Oct 15; 33(3):841-51. PubMed ID: 23042213
    [Abstract] [Full Text] [Related]

  • 4. The consequences of reducing expression of the alpha7 nicotinic receptor by RNA interference and of stimulating its activity with an alpha7 agonist in SH-SY5Y cells indicate that this receptor plays a neuroprotective role in connection with the pathogenesis of Alzheimer's disease.
    Qi XL, Nordberg A, Xiu J, Guan ZZ.
    Neurochem Int; 2007 Oct 15; 51(6-7):377-83. PubMed ID: 17493709
    [Abstract] [Full Text] [Related]

  • 5. Chronic nicotine restores normal Aβ levels and prevents short-term memory and E-LTP impairment in Aβ rat model of Alzheimer's disease.
    Srivareerat M, Tran TT, Salim S, Aleisa AM, Alkadhi KA.
    Neurobiol Aging; 2011 May 15; 32(5):834-44. PubMed ID: 19464074
    [Abstract] [Full Text] [Related]

  • 6. Nicotinic Cholinergic Mechanisms in Alzheimer's Disease.
    Shen J, Wu J.
    Int Rev Neurobiol; 2015 May 15; 124():275-92. PubMed ID: 26472533
    [Abstract] [Full Text] [Related]

  • 7. Beta-amyloid peptide--nicotinic acetylcholine receptor interaction: the two faces of health and disease.
    Dineley KT.
    Front Biosci; 2007 Sep 01; 12():5030-8. PubMed ID: 17569627
    [Abstract] [Full Text] [Related]

  • 8. In vivo pharmacological characterization of a novel selective alpha7 neuronal nicotinic acetylcholine receptor agonist ABT-107: preclinical considerations in Alzheimer's disease.
    Bitner RS, Bunnelle WH, Decker MW, Drescher KU, Kohlhaas KL, Markosyan S, Marsh KC, Nikkel AL, Browman K, Radek R, Anderson DJ, Buccafusco J, Gopalakrishnan M.
    J Pharmacol Exp Ther; 2010 Sep 01; 334(3):875-86. PubMed ID: 20504913
    [Abstract] [Full Text] [Related]

  • 9. Nicotinic acetylcholine receptor interaction with beta-amyloid: molecular, cellular, and physiological consequences.
    Parri RH, Dineley TK.
    Curr Alzheimer Res; 2010 Feb 01; 7(1):27-39. PubMed ID: 20205670
    [Abstract] [Full Text] [Related]

  • 10. Selective coactivation of α7- and α4β2-nicotinic acetylcholine receptors reverses beta-amyloid-induced synaptic dysfunction.
    Roberts JP, Stokoe SA, Sathler MF, Nichols RA, Kim S.
    J Biol Chem; 2021 Feb 01; 296():100402. PubMed ID: 33571523
    [Abstract] [Full Text] [Related]

  • 11. Suppressed expression of nicotinic acetylcholine receptors by nanomolar beta-amyloid peptides in PC12 cells.
    Guan ZZ, Miao H, Tian JY, Unger C, Nordberg A, Zhang X.
    J Neural Transm (Vienna); 2001 Feb 01; 108(12):1417-33. PubMed ID: 11810405
    [Abstract] [Full Text] [Related]

  • 12. Neuronal nicotinic acetylcholine receptors serve as sensitive targets that mediate beta-amyloid neurotoxicity.
    Liu Q, Wu J.
    Acta Pharmacol Sin; 2006 Oct 01; 27(10):1277-86. PubMed ID: 17007734
    [Abstract] [Full Text] [Related]

  • 13. Neuroprotective and Neurotoxic Implications of α7 Nicotinic Acetylcholine Receptor and Aβ Interaction: Therapeutic Options in Alzheimer's Disease.
    Farhat SM, Ahmed T.
    Curr Drug Targets; 2017 Oct 01; 18(13):1537-1544. PubMed ID: 27719660
    [Abstract] [Full Text] [Related]

  • 14. α7 nicotinic acetylcholine receptors in Alzheimer's disease: neuroprotective, neurotrophic or both?
    Hernandez CM, Dineley KT.
    Curr Drug Targets; 2012 May 01; 13(5):613-22. PubMed ID: 22300028
    [Abstract] [Full Text] [Related]

  • 15. Stimulating nicotinic receptors trigger multiple pathways attenuating cytotoxicity in models of Alzheimer's and Parkinson's diseases.
    Kawamata J, Shimohama S.
    J Alzheimers Dis; 2011 May 01; 24 Suppl 2():95-109. PubMed ID: 21403387
    [Abstract] [Full Text] [Related]

  • 16. Role of the nicotinic acetylcholine receptor in Alzheimer's disease pathology and treatment.
    Lombardo S, Maskos U.
    Neuropharmacology; 2015 Sep 01; 96(Pt B):255-62. PubMed ID: 25514383
    [Abstract] [Full Text] [Related]

  • 17. Modeling the binding mechanism of Alzheimer's Aβ1-42 to nicotinic acetylcholine receptors based on similarity with snake α-neurotoxins.
    Maatuk N, Samson AO.
    Neurotoxicology; 2013 Jan 01; 34():236-42. PubMed ID: 23022323
    [Abstract] [Full Text] [Related]

  • 18. High selective expression of alpha7 nicotinic receptors on astrocytes in the brains of patients with sporadic Alzheimer's disease and patients carrying Swedish APP 670/671 mutation: a possible association with neuritic plaques.
    Yu WF, Guan ZZ, Bogdanovic N, Nordberg A.
    Exp Neurol; 2005 Mar 01; 192(1):215-25. PubMed ID: 15698636
    [Abstract] [Full Text] [Related]

  • 19. Beta-amyloid activates the mitogen-activated protein kinase cascade via hippocampal alpha7 nicotinic acetylcholine receptors: In vitro and in vivo mechanisms related to Alzheimer's disease.
    Dineley KT, Westerman M, Bui D, Bell K, Ashe KH, Sweatt JD.
    J Neurosci; 2001 Jun 15; 21(12):4125-33. PubMed ID: 11404397
    [Abstract] [Full Text] [Related]

  • 20. Expression of nicotinic receptors on primary cultures of rat astrocytes and up-regulation of the alpha7, alpha4 and beta2 subunits in response to nanomolar concentrations of the beta-amyloid peptide(1-42).
    Xiu J, Nordberg A, Zhang JT, Guan ZZ.
    Neurochem Int; 2005 Sep 15; 47(4):281-90. PubMed ID: 15955596
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.